← Eichor
Study identifier: NCT05981300 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

GpCRC Pediatric Gastroparesis Registry 2

Condition: Gastroparesis · Gastroparesis-like Syndrome  ·  Sponsor: Johns Hopkins Bloomberg School of Public Health

PhaseN/A
Planned participants216
Who can joinAll sexes, 8 Years to 25 Years
Healthy volunteersNo

About this study

The objective of the Pediatric Gastroparesis Registry 2 is to create a national prospective registry of children, adolescents, and young adults with gastroparesis and gastroparesis-like syndrome (symptoms of gastroparesis but normal gastric emptying).

This description comes directly from the study's public registry record.

Talk to the study team

Laura Miriel  ·  410-955-4165  ·  laura.miriel@jhu.edu

Peggy Adamo  ·  410-502-9137  ·  madamo1@jhu.edu

Always discuss trial participation with your own doctor first.

Locations (6)

Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting
Boston Children's HospitalBoston, Massachusetts, United StatesRecruiting
Nationwide Children's HospitalColumbus, Ohio, United StatesRecruiting
Texas Tech University Health Science CenterEl Paso, Texas, United StatesRecruiting
Baylor College of Medicine/Texas Children's HospitalHouston, Texas, United StatesRecruiting
Medical College of WisconsinMilwaukee, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05981300